Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout
- PMID: 1994910
- DOI: 10.1002/art.1780340203
Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout
Abstract
Synovial fluid (SF) from 74 asymptomatic knees of patients with gout was analyzed. These patients had never been treated with serum uric acid-lowering agents. SF samples were analyzed for the presence of crystals and for cell counts, using undiluted SF directly in a Niebauer cell counting chamber. Thirty-seven of the aspirated knees had previously been inflamed, and monosodium urate (MSU) crystals were seen in SF aspirates from 36 of them (97%). Of the 37 knees that had never been inflamed, only 8 contained MSU crystals (P less than 0.00001). After reaching the joint, MSU crystals will persist in the SF as long as the serum uric acid level has not been lowered by appropriate treatment. In this situation, analysis of SF is an excellent diagnostic test for the intercritical gout. The mean cell count in the 44 SF samples that contained MSU crystals was 449/mm3 (95% confidence interval 310-589); the mean cell count in the 30 SF without MSU crystals was 64/mm3 (95% confidence interval 34-95) (P less than 0.00002). The SF samples that contained MSU crystals also had a higher percentage of polymorphonuclear leukocytes than those without MSU crystals (P less than 0.002). These data suggest that there is a low-grade inflammation present in the knees of patients with MSU crystals, the consequences of which should be investigated.
Similar articles
-
A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout.Br J Rheumatol. 1995 Aug;34(8):724-6. doi: 10.1093/rheumatology/34.8.724. Br J Rheumatol. 1995. PMID: 7551655
-
A method for counting monosodium urate crystals in synovial fluid.Reumatismo. 2015 Jun 30;67(1):29-32. doi: 10.4081/reumatismo.2015.827. Reumatismo. 2015. PMID: 26150273
-
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.Ann Rheum Dis. 2007 Aug;66(8):1056-8. doi: 10.1136/ard.2006.060368. Epub 2007 Jan 12. Ann Rheum Dis. 2007. PMID: 17223663 Free PMC article.
-
Clinical implications of synovial fluid specimen handling for crystal associated arthritides: A systematic review.Int J Rheum Dis. 2021 Jan;24(1):10-20. doi: 10.1111/1756-185X.14019. Epub 2020 Nov 5. Int J Rheum Dis. 2021. PMID: 33150706
-
Diagnosis of gout.Minerva Med. 2007 Dec;98(6):759-67. Minerva Med. 2007. PMID: 18299687 Review.
Cited by
-
Cardiovascular Safety of Urate Lowering Therapies.Curr Rheumatol Rep. 2019 Jul 24;21(9):48. doi: 10.1007/s11926-019-0843-8. Curr Rheumatol Rep. 2019. PMID: 31342190 Review.
-
Longitudinal follow-up study of the association with gout and Alzheimer's disease and Parkinson's disease in Korea.Sci Rep. 2023 Mar 6;13(1):3696. doi: 10.1038/s41598-023-30379-4. Sci Rep. 2023. PMID: 36878976 Free PMC article.
-
Managing Gout in the Patient with Renal Impairment.Drugs Aging. 2018 Apr;35(4):263-273. doi: 10.1007/s40266-018-0517-7. Drugs Aging. 2018. PMID: 29435850 Review.
-
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.Arthritis Res Ther. 2018 Oct 30;20(1):243. doi: 10.1186/s13075-018-1746-1. Arthritis Res Ther. 2018. PMID: 30376864 Free PMC article.
-
Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis.Eur J Prev Cardiol. 2015 Mar;22(3):335-43. doi: 10.1177/2047487313514895. Epub 2013 Nov 26. Eur J Prev Cardiol. 2015. PMID: 24281251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical